RSV Policy Statement —Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection.
Pediatrics
2014;134(2):415–420
2016 ◽
Vol 3
(1)
◽
pp. 38-42
◽